Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by qwerty22on Dec 08, 2021 11:30am
108 Views
Post# 34210655

RE:RE:RE:RE:TH hiring a Project Manager for CMO

RE:RE:RE:RE:TH hiring a Project Manager for CMO

Maybe he should lay out his vision.

Q for the next opportunity we get to ask questions. "You're spending big on new hirings and seem to be building a structure that thtx has never had before. What is your vision for where the company is going and where are the assets to support getting there?"

(Maybe the answer will be obvious if they execute on a major milestone)


qwerty22 wrote:

My guess is this is the type of structure Paul is used to having around him at Merck and he's building something similar. Maybe he believes in the short term this will generate enough sales to cover the extra expense and in the long term the aspiration is for something bigger. You would have to think the present two drugs, in their present state, can only go so far. They need something more from either the R&D projects or the rights to new drugs.

As Palinc keeps saying, there is something super attractive about all the aspirations in the changes Paul is making. The problem for me is do they have the assets to match those aspirations. Obviously if cancer starts to show it's preclinical promise in the clinic or they can get NASH going then either of those would go a long way to filling that deficit. Getting the rights to new drugs would do it as well. The promise is there but right at this moment the assets need to hit milestones to match that aspiration.

It's hard to know whether this structure needs to be in place to attract the right partners and deals or whether they are jumping the gun on getting this structure in place without being certain they have the assets to support it. What seems certain is he's trying to move the company to a different place, it's just not clear yet to what ends.

 

SPCEO1 wrote: + platform.A large percentage of the recent job postings, such as this one, are tilted toward the legacy drugs. Sales of those drugs seem to be improving somewhat but I am still surprised by the spending on them. Maye there is more to it though than just the two old drugs. Perhaps they are in talks to acquire another drug or two to sell as they could really use more product to feed the salesforce in the US. I am not sure what kind of salesforce they even have in Europe - it may just be MSL's there due to the highly centralized aspect of the health care system there.

Also, on the cancer side of the equation, they may be relying more on outside contracters to do much of the work. But I don't like seeing that they have not filled the Drug Discivery Scientist position they posted last April. Hopefully, that is not slowing down the progress of the Sort1+ platform.  
 

 

archeo753 wrote:
SPCEO1 wrote:
sounds like they are getting ready for phase 1b, maybe more than that. Job opening added on LinkedIn.


Also, another new job posting from website.

 

Position Summary

Reporting to the Senior Manager, Global Market Analytics, the incumbent support the Sales and Commercial Operation leadership to assess, identify and predict areas of opportunity in enhancing field force efficiency and productivity. The MFFA provides in-depth analysis of sales data to understand national and territory-level trends, provides actionable insights and accelerates decisions.

Key Responsibilities

  • Using analytic methods and data from multiple sources to provide insights as it relates to customer segmentation, targeting and field analytics
  • Supports call plan development including territory design, mapping and alignments as well as ensuring cross functional collaboration and communication with Sales, Commercial Operations and Marketing teams.
  • Support the design and tracking of the incentive compensation plan for the field team
  • Develop and monitor field metrics to be included in reports, scorecards and performance dashboards. Provide planned as well as ad-hoc analysis of these metrics
  • Using the appropriate methodology, analyze the physician response to various promotional efforts and supports effective resource management by assisting in allocation strategy
  • Work with third party vendor to drive efficiency in the delivery of patient support program data and conducts patient level analytics, including new starts, patient adherence/compliance and demographic drivers’ assessments to support marketing and sales strategy
  • Work with the Sr. Manager, Global Market Analytics to understand business performance drivers and provide data-based recommendations that contribute to achieve corporate objectives and support the ongoing growth of the organization

Qualifications Required

  • 5+ years of relevant experience in sales analytics, sales force effectiveness or operations in the healthcare industry
  • Bachelor's Degree (or related credentials) in: Business, Economics, Statistics, Health Science or extensive pharmaceutical experience
  • Demonstrated experience in providing field force analysis to support field reporting, customer segmentation, field force sizing and incentive compensation
  • Experience in analyzing large data sets to draw conclusions and develop actionable recommendations
  • Experience with Data Visualization and dashboard platforms, (such as Tableau) to extract and analyze data
  • Experience with Veeva or comparable CRM tool
  • Ability to build relationships and connect with key stakeholders across the organization
  • Capacity to work under pressure, multi-task and adhere to deadlines
  • Excellent written and oral communication skills
  • Strong understanding of MS Office applications

 

 




<< Previous
Bullboard Posts
Next >>